ERBB2 c.2333_2334insTAGCCCTGG ;(p.G778_P780dup)

Variant ID: 17-37881002-G-GGGTAGCCCT

NM_004448.2(ERBB2):c.2333_2334insTAGCCCTGG;(p.G778_P780dup)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Treatment outcome and clinical characteristics of HER2 mutated advanced non-small cell lung cancer patients in China.

Thoracic Cancer
Xu, Fei F; Yang, Guangjian G; Xu, Haiyan H; Yang, Lu L; Qiu, Weini W; Wang, Yan Y
Publication Date: 2020-03

Variant appearance in text: HER2: Val777_Gly778insGlySerPro
PubMed Link: 31975535
Variant Present in the following documents:
  • Main text
  • TCA-11-679.pdf
View BVdb publication page



KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.

Therapeutic Advances In Medical Oncology
Cinausero, Marika M; Laprovitera, Noemi N; De Maglio, Giovanna G; Gerratana, Lorenzo L; Riefolo, Mattia M; Macerelli, Marianna M; Fiorentino, Michelangelo M; Porcellini, Elisa E; Buoro, Vanessa V; Gelsomino, Francesco F; Squadrilli, Anna A; Fasola, Gianpiero G; Negrini, Massimo M; Tiseo, Marcello M; Ferracin, Manuela M; Ardizzoni, Andrea A
Publication Date: 2019

Variant appearance in text: ERBB2: V777_G778insGSP
PubMed Link: 31798692
Variant Present in the following documents:
  • Main text
  • 10.1177_1758835919885540.pdf
View BVdb publication page